CLINICIAN- AND PATIENT-REPORTED OUTCOMES OF STEREOTACTIC ABLATIVE RADIOTHERAPY FOR HIGH-RISK PROSTATE CANCER.
Logar HB, Montero A, Hernando O, Lopez M, Valero J, Ciervide R, Alvarez B, Chen-Zhao X, Sanchez E, Garcia-Aranda M, Saiz C, Zucca D, Alonso L, Sanchez M, Alonso R, Fernandez-Leton P, Rubio C.
Logar HB, et al.
Pract Radiat Oncol. 2025 Jun 9:S1879-8500(25)00151-1. doi: 10.1016/j.prro.2025.05.007. Online ahead of print.
Pract Radiat Oncol. 2025.
PMID: 40499812